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Introduction
Maintaining good cognitive health is of critical importance in 
a time where there are increasing numbers of older individuals. 
Aging is associated with alterations in the structure and func-
tion of the brain and the vascular system that supports it. 
There is growing evidence that age-related declines in cardio-
vascular and neurocognitive function are intrinsically linked.1–4 
Arterial health has emerged as a significant predictor of cog-
nitive performance, and both arterial health and cognitive per-
formance have been shown to decline with increasing age, an 
indication that there is an age-dependent association between 
the two.5 Cerebral blood flow (CBF) decreases with advancing 
age,6 and this reduction is associated with cognitive decline.7 
Peripheral arterial stiffness has been shown to predict cogni-
tive performance in a group of healthy middle-aged adults.8 
The connection between brain and vascular health is undoubt-
edly significant; however, the intrinsic nature of this connec-
tion is unclear.
Blood-oxygen-level dependent contrast imaging (BOLD) 
functional magnetic resonance imaging (fMRI) studies of 
cognitive aging have provided an abundance of information 
about the brain. Normal physiological aging in the absence 
of pathology is linked with various alterations in the vascula-
ture of the brain, both functionally and structurally.9 
Endothelium-dependent cerebrovascular reactivity (CVR) is 
a main regulatory mechanism that controls CBR.10,11 CVR 
refers to a vasodilatory or vasoconstrictor response of the 
blood vessels to a stimulus, and this measure provides a direct 
assessment of vascular brain health.12 Impaired CVR indi-
cates microvascular hemodynamic dysfunction, which is 
implicated in many brain disorders, including stroke13 and 
Alzheimer’s disease (AD),14–16 as well as mild cognitive 
impairment.17
The CVR index reflects the response of cerebral blood ves-
sels to extrinsic stimulation by vasodilators such as acetazola-
mide18,19 or hypercapnic challenge.20,21 Hypercapnia can be 
induced through inhalation of CO2-enriched gas, which is a 
harmless way to investigate the effects of vascular functioning 
on the blood flow parameters in the brain.22–27 Vasodilation in 
response to CO2 enhances CBR through diameter enlarge-
ment in the small arterioles, making it possible to evaluate the 
function of small intra-cerebral vasomotor vessels.28
Age differences in CVR
Increasing evidence shows that the cerebral vessel contractility and 
dilation becomes diminished in later life, consequently impacting 
neurovascular coupling.29 Multiple biochemical elements have 
been suggested as responsible for this loss of function, including 
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reduced production and release of vasodilatory substances such as 
nitric oxide (NO), and increasing production of vasoconstrictive 
factors by the cerebral endothelium.9 The vascular wall is also 
affected structurally in the normal aging process; thickening of the 
basement membrane by augmented collagen and losses of smooth 
muscle and elastin occurs frequently.30 Atherosclerosis is also 
common, even in healthy aging, and further reduces the capacity 
for control of vascular diameter and tone. These alterations lead to 
the progressive stiffening of the cerebral blood vessels, resulting in 
a reduced capacity for dynamic control of blood flow in response 
to neural demand.31,32 These differences in vascular responsiveness 
between younger and older adults have implications for the inter-
pretation of BOLD fMRI data in aging research.33
Age-related differences in CVR have been studied widely, 
though evidence is mixed. While most reports indicate that 
blood vessel reactivity in the brain decreases with age,32,34–39 
other studies have found that vasomotor reactivity increases,40 
or remains the same across the lifespan.41,42
Discrepancies between the type of vasodilatory stimuli, 
brain regions studied, age ranges, methodologies, and data 
analysis cloud the interpretation of studies of CVR in aging. 
While it is likely that vasomotor responsiveness in the brain 
diminishes due to the known physiological changes that occur 
in the vasculature with age, age-related alterations in CVR 
remain to be elucidated.
Regional differences in CVR
Reactivity in the brain is temporally dynamic, differs between 
vascular territories, and is heterogeneous across regions,43,44 
though the findings are inconsistent. Research has shown 
that regional CVR is higher in the parietal and occipital areas 
when compared to frontal, temporal and insula cortices43 yet 
others have found the greatest reactivity in the cerebellum 
and visual cortex, with the least in the frontal lobes.45 Grey 
matter has up to three times greater reactivity than white 
matter.21,23 Furthermore, the effects of normal aging on 
regional CVR remain inconclusive, and the question of 
whether some areas are more affected than others remains. 
The known heterogeneity of age-related changes in regional 
CBF12 would indicate that CVR also varies between brain 
regions, and that vascular responsiveness may alter over time 
differently in differing areas.
One study15 reported that the posterior regions of the brain 
were more predominantly dysfunctional than other areas in a 
study of AD patients versus healthy controls, and CVR in 
these areas was correlated with cognitive performance, sug-
gesting that the relationship between reactivity and cognitive 
impairment may be region-dependent. Evidently further 
research is necessary to clarify the regional distribution of 
vasoreactivity changes in the aging brain, as regions with a 
lower vasodilatory capacity could be more affected by reduced 
perfusion than areas that have greater reactivity, potentially 
contributing to cognitive losses in the elderly.46
Cognition and CVR
Given the predictive relationship of vascular health and cogni-
tive performance,47,48 CVR has been examined for its relation-
ship to cognition. Changes to the integrity of the cerebrovascular 
system can bring about cognitive change due to dysfunctional 
neurovascular coupling.43 Vascular disorders have been shown to 
contribute to neurodegenerative and cognitive illnesses.2,4,49,50 
Associations between impaired CVR and severity of dementia 
have been established.51,52 CVR assessed by the breath-holding 
index (BHI) was found to be the best predictor of cognitive per-
formance in AD over and above gender, age, education, and vas-
cular risk factors,51 and pathological BHI is also predictive of 
conversion from MCI to AD.53 One study in cognitively healthy 
patients with peripheral artery disease reported that CVR was 
linked to executive function, memory, global cognition, and 
attention scores.54 While the vessel reactivity-cognition link has 
often been investigated in cardiovascular and neurodegenerative 
disorders, particularly AD, the association between cerebrovas-
cular function and cognition in healthy aging is yet to be clari-
fied. If impaired vascular reactivity is found to be implicated in 
cognitive performance, vaso-protective therapies may be a target 
for prevention of age-related cognitive decline.
The goal of the present study was to further this research by 
using MRI to measure the BOLD signal during CO2 inhalation 
in healthy, normally aging adults to assess differences in CVR 
across the lifespan. A cognitive assessment was performed to 
ascertain the relationships between cognition and cerebrovascu-
lar function in healthy aging. Second, it was of interest to inves-
tigate whether reactivity was the same across different brain 
regions, that is, was the age-related change in CVR heterogene-
ous throughout the brain, or are some regions more affected than 
others. Additionally, the relationships of regional CVR to cogni-
tive performance on measures of memory and attention were 
examined to explore whether these cognitive domains are dif-
ferentially affected by CVR in distinct brain regions.
Based on previous research, it was expected that CVR values 
would vary across regions and CVR would decline with 
age.7,21,45 Also expected was a positive association between 
CVR and cognition, such that greater reactivity would be cor-
related with better performance.15,54
Results
Characteristics of sample are shown in Table 1 below. The 
younger group was significantly more educated, with lower 
body mass index (BMI) and larger grey matter volumes than 
the older group. Reaction times on the memory and attention 
tasks were significantly faster in the younger group.
CVR is reduced in some regions with age
When using age as a continuous variable, CVR in the temporal 
lobe was found to significantly decrease with age (r = -0.43, 
P = .002). An independent t-test revealed that CVR in the 
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temporal lobes was higher in the younger compared to the 
older group, F(1, 50) = 2.58, P = .006. No other regions-of-
interest (ROIs) showed significant change with age in the sam-
ple as a whole.
After separating the cohort into age groups, it was observed 
that CVR was significantly reduced in the cingulum (r = –0.54, 
P = .008), grey matter (r = –0.54, P = .006) and temporal (r = –0.52, 
P = .006) areas in the older group. The grey matter and temporal 
areas still showed a marginally significant reduction after correc-
tion for multiple comparisons. A graphical representation of the 
percentage change in BOLD signal in the temporal lobes plot-
ted with the change in etCO2 is shown in Figure 1, separated by 
age group. CVR did not change significantly with age in any of 
the ROI in the younger group. Figure 2 shows the mean regional 
CVR values for each group. There were no significant differ-
ences between genders in CVR in any region studied across the 
lifespan, nor when separated into age groups.
Temporal lobe CVR predicts cognition across the 
lifespan
In the sample as a whole, correlations between cognitive var-
iables and CVR were observed. CVR in the temporal lobes 
was associated with both memory (r = –0.46, P = .001) and 
attention performance (r = –0.41, P = .003). Table 2 displays 
results of separate unadjusted linear regressions for temporal 
lobe CVR and cognitive score. Greater CVR was associated 
with faster reaction times. Linear regression analyses showed 
that CVR in the temporal lobes significantly predicted 
memory score, and this effect was independent of age, gender 
and years of education. Figure 3 shows the relationship 
between temporal lobe CVR and memory task reaction 
times. A second linear regression showed that attention was 
not significantly predicted by temporal lobe CVR when 
adjusted for age, gender and education, though the model 
itself was significant. Table 3 shows the results of separate 
adjusted linear regression analyses.
Hippocampal CVR predicts memory score in older 
adults
When separated by age group, separate linear regressions showed 
that in the younger sample there were no significant associations 
between CVR in any brain region and either cognitive measure. 
In the older group however, CVR in the hippocampus signifi-
cantly predicted memory score, F(1, 20) = 5.83, P = .026, with an 
R2 of .24. CVR in the hippocampus was negatively associated 
with memory score such that worse CVR reflected longer 
Table 1. Means, standard deviations for characteristics of the study population.
WHOlE SAMPlE
AgE RANgE 21-75 
(M: 47.22, SD: 18.59)
N = 59
YOUNgER
AgE RANgE 21-44
(M: 30.03, SD: 6.22)
N = 30
OlDER
AgE RANgE 55-75
(M: 65, SD: 5.57)
N = 29
Years of education 17.18 (3.69)* 18.37 (3.22) 15.81 (3.77)
TICS-m 29.36 (2.40)
MAC-Q 23.83 (3.57)
BMI 23.98 (4.03)* 22.61 (3.21) 25.45 (4.35)
Heart rate 66.98 (9.87) 67.46 (9.63) 66.50 (10.26)
Systolic pressure, mmHg 127.11 (16.31) 124.11 (16.32) 129.90 (16.09)
Diastolic pressure, mmHg 75.82 (10.76) 73.56 (10.69) 77.93 (10.57)
gmCBF, ml/100 g/min 45.04 (9.05) 45.54 (9.01) 44.52 (9.21)
gMV, cm3 703.99 (85.42) ** 753.44 (73.77) 652.83 (64.40)
WMV, cm3 481.68 (56.46) 487.34 (60.66) 475.83 (52.18)
Baseline etCO2, mmHg 38.27 (4.55) 39.06 (4.18) 37.42 (4.85)
Hypercapnia etCO2, mmHg 46.09 (4.33) 46.88 (4.03) 45.24 (4.55)
ΔetCO2, mmHg 7.82 (2.26) 7.81 (2.32) 7.82 (2.26)
Memory mean RT, ms 908.19 (113.16) ** 839.05 (87.08) 982.10 (88.92)
Attention mean RT, ms 529.65 (84.30)** 472.78 (62.32) 586.51 (62.31)
TICS-m: modified Telephone Interview for Cognitive Status; MAC-Q: Memory Complaint Questionnaire; BMI: body mass index; gmCBF: grey matter cerebral blood flow; 
gMV: grey matter volume; WMV: white matter volume; etCO2: end-tidal CO2.
Values displayed are M (SD).
*P < .01, **P < .001, significant differences between younger and older groups.
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response times (ie, slower processing). Attention was not associ-
ated with CVR in any brain region in either age group.
Scores on the MAC-Q were significantly correlated with 
hippocampal CVR (r = –0.439, P = .046), lower CVR was asso-
ciated with greater subjective memory complaints in the older 
group. Additionally, there was a marginally significant correla-
tion between hippocampal CVR and TICS-m score in the 
older group (r = 0.46, P = .056), suggesting a trend toward a 
relationship between global cognitive impairment and regional 
reactivity in elderly individuals.
Summary of f indings
As a whole, (1) CVR declined with age in the temporal lobes 
across the lifespan, (2) CVR in the temporal lobes was associ-
ated with memory and attention scores, and (3) when adjusted 
for age, gender and education, temporal lobe CVR predicted 
memory score across the entire sample.
When the sample was split into age groups, (1) there were 
significant declines in CVR in several regions with age in the 
older group, but these declines were not seen in the younger 
group; (2) there was a significant association between CVR in the 
hippocampus and memory score in the older sample, but mem-
ory was not related to CVR in any region in the younger group; 
(3) CVR was not associated with attention score in either group; 
and (4) lower CVR was associated with greater subjective mem-
ory concerns and global cognitive impairment in the older group.
Discussion
The present study investigated age-related differences in 
regional CVR to carbon dioxide in healthy younger and older 
adults, and the relationships between regional CVR and cogni-
tive performance. It was expected that an age-related CVR 
decline would be observed between the younger and older 
groups, and that this decline would vary between brain regions.55 
Also expected was a positive association between CVR and cog-
nition, such that greater reactivity would be correlated with bet-
ter performance.15,54 Temporal lobe CVR predicted memory 
score independent of age, gender, and education across the 
entire sample. Hippocampal CVR significantly predicted mem-
ory score in the older group and was negatively associated with 
subjective memory complaints. Consistent with literature, both 
measures of cognition declined with increasing age. This is the 
first study to examine the differences in regional CVR between 
younger and older cognitively healthy individuals in relation to 
performance on memory and attention tasks. Findings demon-
strate that reactivity is linked to cognition in both regionally 
and task-specific ways in older healthy adults.
Age and regional differences in CVR
While CVR was lower in the older group in several regions 
studied, these declines were not significant in all areas. The 
temporal lobes showed significant reductions in reactivity 
between the younger and older groups. Reactivity declined sig-
nificantly in the cortical grey matter, the cingulum and the 
temporal lobes in older adults with age, but no age effects were 
seen in the younger adults. These findings are in line with 
Figure 1. Percentage change in etCO2 and BOLD signal in the temporal 
lobe ROI in response to the hypercapnic challenge. Each marker on the 
x-axis represents 3 seconds (1 TR). BOlD traces have been shifted to the 
right-young by 9 seconds (3 TR), and older by 18 seconds (6 TR), which 
yielded the maximum cross-correlation between etCO2 and BOlD 
signals for this ROI. lines representing younger and older adults are 
displayed in different colors. Shaded area indicates the hypercapnia 
period. The etCO2 data points extracted for CVR analysis are indicated 
by the black lines below the x-axis. To calculate CVR, BOlD data points 
were extracted and averaged across a 30 second period during 
hypercapnia and final 30 seconds of the baseline period preceding 
gas-inhalation separately by group (66-96 seconds after the CO2-
inhalation began in the younger group and 72-102 seconds in the older 
group). After aligning the signals at the maximum cross-correlation, the 
time from the gas-inhalation onset to 50% of the maximum BOlD signal 
change was calculated for each group for the temporal lobe ROI, younger 
47 seconds, and older 51 seconds, though an independent-samples t-test 
showed that these differences were not significant (P = .52).
Figure 2. Regional CVR values for younger and older adults. Mean 
cerebrovascular reactivity values for ROIs averaged across groups.
gM grey matter.
All ROIS were bilateral, masked with a grey matter mask with a 50% probability 
threshold.
**P < .01.
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previous research that reported heterogeneous declines from 
younger to older age.12
Mechanisms underlying the decreasing reactivity of cerebral 
vessels with age can be explained by well-described age-associ-
ated vascular stiffening.29 The more distensible, elastic proper-
ties of blood vessel walls are known to deteriorate, and 
regenerate more slowly in aged individuals, while the more 
rigid wall components, such as collagen and the basement 
membrane, may be augmented.43 This results in the vessel wall 
becoming stiffer with time, even in the absence of pathology. 
Arteriosclerosis can also be prevalent to some degree even in 
healthy aging, adding to the rigidity of vessels.9 A third insult 
that occurs with aging is the over-production or release of 
vasoconstrictive substances such as endothelin-1, and the 
diminished release of vasodilatory chemicals such as NO.30 
Underproduction of vasodilators by the endothelium will result 
in reduced capacity for dilation or possibly even hyper-con-
striction, observed as impaired responsiveness. Most MRI-
based reports of regional CVR decline suggest that diminishing 
vasomotor responses are widespread and generally will encom-
pass most areas of the brain, and that the decline in CVR is 
more abundant and pervasive both spatially and in percentage 
than the decline in CBF.32
CVR was heterogeneous across brain regions. Reactivity was 
higher in the parietal, temporal, and frontal areas, and lowest in 
the hippocampus and cingulate. This is corroborated by previous 
research indicating that CVR is greater in the cortical grey mat-
ter when compared to the deeper grey matter structures.43 
Studies investigating the spatial distribution of small vessel reac-
tivity have observed widely varying values between areas, varia-
tion even between vascular territories supplied by the same major 
arteries has been observed.35 Variability between regions is likely 
due to differences in vascular structure and density, and occurs 
due to the spatial inhomogeneity and temporally dynamic nature 
of blood flow, in addition to differing neural and metabolic 
demands in different parts of the brain.44 ROIs assessed in the 
current work were intersected with grey matter masks, which we 
expected would reduce any atrophy-related variability between 
younger and older adults, thus providing a relative measurement 
of reactivity not confounded by age-related volume differences.
CVR in the temporal lobes was associated with both 
memory and attention
To our knowledge, this is the first study to assess the contribution 
of CVR in specific brain regions to attention and memory in cog-
nitively healthy adults with ages ranging across the adult lifespan. 
It was observed that better vascular reactivity in the temporal lobes 
was associated with faster reaction times on both memory and 
attention tasks. These associations were region-, task- and age-
dependent. When the effects of age, gender and education were 
controlled for, the relationship between temporal CVR and mem-
ory remained significant. These findings are corroborated by 
research aligning vascular reactivity with cognitive scores in patient 
groups of AD,15,51 vascular dementia,56 and mild cognitive 
impairment.53 Elucidating the patterns of change in reactivity that 
occur with cognitive change is important; one study observed that 
there was a 33% chance of conversion from MCI to AD within a 
year for those MCI patients who had pathologically low CVR.53
CVR in the hippocampus significantly predicted 
memory score in older adults
Additionally, we aimed to assess differences between younger 
and older individuals, and found that when comparing the 
groups, there were significantly different relationships in 
Table 2. Showing results of separate unadjusted linear regressions for temporal lobe CVR contribution to memory and attention scores for the 
entire sample.
MEMORY ATTENTION
 B SE B β B SE B β
–979.62 268.93 –0.46 –647.14 207.45 –0.31
R2 0.21 0.17  
F 13.27*** 9.73**  
**P < .01, ***P < .001.
Figure 3. Scatterplot showing the relationship between CVR in the 
temporal lobes and memory reaction times for the entire sample. Data for 
younger and older groups are shown in different colors. Black line 
indicates trend for whole sample data. An adjusted linear regression 
analysis showed the temporal lobe CVR predicted memory score 
independent of age, gender and education (P < .01).
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regional CVR effects on cognition. Vascular reactivity in the 
bilateral hippocampus was linked to memory performance in 
the older group, yet this relationship was not observed in 
younger adults. Previous research found that vasoreactivity in 
the hippocampus is reduced in cognitively impaired individuals 
compared to healthy controls57; however, this is the first study 
to show a direct correlation between memory function and 
hippocampal CVR in cognitively healthy individuals. Much 
evidence has shown the association of hippocampal volume58 
and perfusion59,60 to various memory functions, though the 
impact of integrity of the small vessels supplying this structure 
are less well understood. This novel finding highlights the con-
tribution of vascular integrity to a distinct cognitive domain 
both regionally and functionally. This result is not surprising, 
given the evidence showing that impaired vessel function can 
lead to changes in perfusion, possibly culminating in damage to 
brain regions that are strategic for memory functions.43 The 
hippocampus is particularly vulnerable to damage from 
ischemia and is notably damaged by AD pathology. 
Dysfunctional reactivity reduces perfusion, potentially result-
ing in greater cognitive losses in those at risk.
Another notable finding is the significant relationship 
between subjective memory complaints and hippocampal 
CVR. Greater reactivity was associated with less memory con-
cerns. Previous research has linked smaller hippocampal vol-
ume to subjective memory problems in cognitively healthy 
people,61 yet this is the first study to examine this relationship 
with CVR. Subjective memory concerns may precede demen-
tia and those with subjective complaints are more likely to 
experience cognitive decline.62,63 Our findings suggest that 
vascular regional changes may be a part of the early pathologi-
cal process and serve as a first step in disentangling the rela-
tionship between memory deficits and brain atrophy findings.
Highly responsive blood vessels are essential for optimum 
flow-metabolism coupling. Impaired CVR is an indication of 
underlying microvascular dysfunction wherein the metaboli-
cally active regions of the brain will not be supplied adequately 
to meet demands. This hypoperfusion can lead to chronic 
ischemia over time, potentially preceding neurological and 
cognitive impairments.64 Indeed, research has shown strong 
evidence of vascular origins in the development and progres-
sion of AD.4,49,65
Limitations
The results of this study should be viewed in light of some 
limitations. Common to all neuroscientific aging research, 
brain atrophy can present some issues with comparability 
between age groups. In the present study, CVR values were cal-
culated such that they are absolute measures; however, care was 
taken to ensure that all ROIs from which the data were 
extracted were masked with the grey matter probability map to 
account for individual differences in partial volume and tissue 
atrophy. This validated procedure has been utilized 
previously.7
Additionally, it should be noted that inhalation of CO2-
enriched gas does not provide a precise standard arterial partial 
pressure of CO2 (PaCO2) stimulus, due to variability in indi-
vidual respiratory responses.66 While more exact methods of 
increasing PaCO2 exist (eg, computer-controlled targeting of 
end-tidal CO2 partial pressures), these are expensive and 
require specific equipment and are thus not as accessible. A 
recent review of MRI-based CVR studies by the authors67 
found that inhalation of a fixed concentration of CO2-enriched 
gas was the most commonly used vasoactive stimuli.
The regional CVR values were calculated from the differ-
ence in etCO2 signal from the first 30 seconds of room air 
breathing to the last 30 seconds of CO2 inhalation, while the 
BOLD values were calculated on the basis of age group. BOLD 
signal traces were shifted backward to account for the hemody-
namic lag, in order to align the expired gas signal with the 
increase in BOLD signal. It was found that the younger group 
had slightly shorter hemodynamic lag than the older group 
(9 seconds versus 18 seconds), thus the data points sampled for 
the CVR calculation were different based on age group. While 
this shifting is valid and has been used in previous research,7 
various other sampling methods are available. Future studies 
may benefit from analyzing CVR using other sampled 
Table 3. Showing results of adjusted linear regression for temporal lobe CVR contribution to memory and attention score for the entire sample.
MEMORY ATTENTION
 B SE B β B SE B β
Age 3.14 0.76 –0.51*** 3.02 0.56 –0.67***
gender –46.07 25.12 –0.20 –6.31 18.74 –0.04
Education (years) 1.17 3.50 0.04 5.61 2.61 0.24*
Temporal lobe CVR –626.24 265.20 –0.29** –331.54 –196.87 –0.20
R2 0.52 0.54  
F 11.75*** 12.16***  
*P < .05, **P < .01, ***P < .001.
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time-points, for example, averaging the data points from the 
30 seconds preceding the maximum BOLD signal value 
reached post-CO2 inhalation. This would ensure that the max-
imum signal change is captured for estimating CVR.
Conclusions
In this study, we examined the differences in regional CVR 
between older and younger healthy adults and investigated the 
associations of regional CVR to cognitive performance. The cur-
rent data highlight the association between brain vascular reactiv-
ity and cognitive function; better performance was associated with 
greater blood vessel responsiveness, particularly in regions directly 
associated with memory function. The identification of cerebro-
vascular impairment in aging could help to distinguish those who 
would benefit from vascular-specific therapeutic approaches, and 
could potentially lead to detection of early dysfunction of the vas-
cular system in people at risk. These findings could inform other 
areas of research for implications of vascular stiffening in the brain, 
and provide impetus for vascular-specific therapeutic targets to 
help maintain cognitive functions over the lifespan.
Experimental Procedure
Participants
In all, 30 younger (aged 21–44, mean age 30 years, SD: 6.22 years, 
12 females) and 29 older (aged 55-75, mean age 65 years, SD 
5.57 years, 18 females) healthy (ie, active, independently-living, 
asymptomatic) adults were recruited from the community. 
Participants underwent telephone screening and had no con-
traindications for MRI scanning (no pacemaker, metallic 
implants, or claustrophobia). Participants were of generally 
good health, with no self-reported history of neurological, psy-
chiatric, cardiovascular or inflammatory diseases, and not suf-
fering from asthma or other respiratory problems. The Modified 
Telephone Interview for Cognitive Status- (TICS-m68) was 
used to screen for mild cognitive impairment and dementia for 
participants aged over 45 years. Participants scoring 23 or below 
were omitted from the final analysis (n = 3). The Memory 
Complaint Questionnaire (MAC-Q)69 was used to quantify 
subjective memory complaints in the older participants. After 
receiving an explanation of the study procedure, participants 
provided written informed consent. The research protocol was 
approved by both the Swinburne University Human Research 
Ethics Committee and the Alfred Hospital Human Research 
Ethics Committee, and was conducted in accordance with the 
Australian Code for the Responsible Conduct of Research. 
Regional CVR was measured in a total of 54 participants; some 
data were lost due to motion in the scanner. Table 1 lists the 
demographic information for the participants.
Experimental design and procedure
Data were acquired in one testing session of approximately 
3 hours’ duration. Participant’s blood pressure was taken before 
and after an initial 5-minute gas-breathing procedure con-
ducted outside the scanner. A registered nurse was present for 
this familiarization in which each subjects’ SpO2 was constantly 
monitored. Participants then underwent magnetic resonance 
imaging (MRI) scanning during which they inhaled CO2 twice 
over a period of 10 minutes (see Figure 4). After MRI scan-
ning, participants underwent a 30-minute computerized cog-
nitive assessment.
MRI data acquisition
Data were collected using a 3T Siemens Tim Trio MRI scan-
ner (Siemens, Erlangen, Germany) fitted with a 32 channel 
head coil at Swinburne University of Technology (Hawthorn, 
Australia). Participants were requested to minimize head 
movements, and foam padding was inserted around the head 
to aid this.
Data from two hypercapnia scans were sampled and averaged 
for analysis. Hypercapnia was induced by inhalation of gas mix-
ture containing 5% CO2, 21% O2, and 74% N2 that was delivered 
from a 100 L non-diffusing Douglas bag through a mouth-piece 
with nose-clip to ensure mouth-only breathing. A two-way valve 
allowed the researcher to manually switch between CO2-
enriched gas and room air for the 2 x 5-minute scans, as 
instructed by a visual signal from the MR operator. Gas delivery 
was alternated: 1 min room air, 2 min CO2, and 2 min room air. 
The breathing apparatus is shown in Figure 5. An MRI-safe 
patient monitor (Medrad Veris system, Bayer HealthCare AG, 
Leverkusen, Germany) continuously recorded a digital output of 
participants’ vital signs (heart rate, arterial oxygen saturation, res-
piratory rate), as well as end-tidal CO2 (etCO2).
In all, 14 axial slices with in-plane resolution of 3.44 x 
3.44 x 5 mm, 2.5 mm apart were acquired oblique to the 
commissural plane (shown in Figure 6A and B). Hypercapnia 
scans were acquired using PASL with a PICORE/Q2TIPS 
Figure 4. Experimental design of the hypercapnia scans. 5% CO2 
inhalation was used to induce hypercapnia. Blue line indicates the period 
where baseline etCO2 data were collected, orange line indicates the 
period where hypercapnia etCO2 data was collected. The BOlD data 
points were extracted from the average point of maximum signal change 
across all ROIs to the 30 seconds preceding. This equated to the 
sampled BOlD data points during the hypercapnia period being selected 
from 66 to 96 seconds after CO2 switched on in the younger group, and 
72-102 seconds after CO2 switched on in the older group.
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tagging sequence, in accordance with similar research on 
vasoreactivity.70–72 Gradient-echo echoplanar (EPI) readout, 
TI1 = 700 ms, TI2 = 1500 ms, tag-size = 20 cm, TR = 3000 ms, 
TE = 13 ms, flip-angle = 90°. T1-weighted structural images 
were obtained using a high resolution MPRAGE 3D ana-
tomical scan (axial, TR = 2300 ms, TE = 2.52 ms, voxel-
size = 1 x 1 x 1 mm3, FOV = 256 mm, 176 slices).
Data analysis
CVR data were processed using SPM12 (SPM12, University 
College of London, UK) and associated toolboxes, in addition 
to in-house tools, all run on MATLAB 2014b (The 
MathWorks). All data were motion-corrected, co-registered 
to individual T1-weighted images, normalized to the stereo-
tactic space defined by the Montreal Neurologic Institute 
(MNI space), and then spatially smoothed with 8 mm 
FWHM Gaussian filter. The data were separated into CBF 
and BOLD time-series using the surround subtraction and 
averaging method70 as per Chen and Parrish.71 CVR based on 
BOLD were calculated. CBF-based CVR values are not 
reported in this paper.
Age-related changes in CVR were explored using ROI anal-
ysis. Seven ROIs were chosen based on previous reports in the 
literature.7,21 These regions were the bilateral superior parietal, 
mid-occipital, frontal, mid-temporal, insula, hippocampus and 
the cingulum (ROIs are shown in Figure 6C) and were applied 
to the data to extract BOLD time-courses. Mean whole brain 
grey matter was also used as an ROI. These regions were defined 
from the AAL package in WFU PickAtlas toolbox73 for SPM12.
Grey and white matter volumes were obtained using stand-
ard segmentation in VBM8 software from SPM12. Individual 
grey matter masks from the VBM analysis were smoothed to 
the resolution of the BOLD time-series. To account for partial 
volume and atrophy effects, the grey matter masks were set 
with a threshold of .5 (>50% probability to be grey matter) and 
the intersection with each ROI was used for final CVR analy-
sis. CVR in the whole grey matter was also estimated using the 
thresholded grey matter mask as the ROI for each individual. 
This adjustment corrects for brain tissue volume differences. 
CBF in the grey matter at baseline was calculated from the 
ASL scans, values shown in Table 1.
CVR calculation
The two hypercapnia blocks (Figure 1) were averaged for each 
subject prior to computing the percentage change in BOLD 
relative to baseline for each ROI. Baseline etCO2 data were 
calculated from the final 30 seconds of the room air period at 
the beginning of each scan, and etCO2 for the hypercapnia 
period was calculated from the final 30 seconds of each CO2 
inhalation block. Due to variable hemodynamic delays, each 
subject’s BOLD signal for the hypercapnia period were 
extracted from the point of average maximum signal change 
across all ROIS and the 30 seconds preceding, which equated 
to time-points 66–96 seconds for younger and 72–102 seconds 
for the older group, following the beginning of the CO2-
inhalation period. Baseline BOLD data were calculated from 
the final 30 seconds of the room air period at the beginning of 
each scan. Data were sampled from different points in order to 
Figure 5. Breathing apparatus (a) 100 l Douglas bag, (b) 3-way valve, (c) 
2-way non-rebreathing valve, (d) nose-clip, (e) filter (gas-sampling tube 
attaches here, not shown), and (f) mouth-piece.
Figure 6. MRI slice positioning and brain regions of interest (ROIs) (A) 
sagittal view, (B) coronal view, and (C) ROIs included the bilateral 
parietal, occipital, frontal, temporal, insula, hippocampus and cingulum.
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obtain the maximum CVR change for each group across all 
ROIs. Both BOLD and etCO2 data were temporally smoothed 
by a 5-point moving average filter using the “smooth” function 
in MATLAB. CVR was calculated as the %change in BOLD/ 
mmHg change in etCO2.
To assess differences in hemodynamic delay between the 
age groups, the time to 50% of the maximum value from begin-
ning of the CO2 mixture inhalation was computed for each 
group and each ROI separately.
Cognitive assessment
Screening tool- Modif ied Telephone Interview for Cognitive Sta-
tus (TICS-m). The TICS-m is a reliable and validated brief 
13-item test of cognitive functioning that is administered 
over the telephone.68 The items covered related to questions 
of orientation, repetition, naming, calculations and immedi-
ate and delayed recall with scores ranging from 0 to 35. Par-
ticipants who scored 23 or below were omitted from the final 
analysis (n = 3).
Memory Complaint Questionnaire (MAC-Q). The MAC-Q69 
is designed to quantify subjective memory complaints associ-
ated with aging. It consists of six questions which ask the par-
ticipant to compare their current everyday memory to that of 
earlier life. Possible score range is from 7 to 35. Greater scores 
indicate greater subjective memory concerns.
Swinburne University Computerized Cognitive Aging Battery 
(SUCCAB). The SUCCAB is described previously in Pipin-
gas et al.74 Participants were given instructions on how to per-
form each task and completed a practice task prior to 
performing the main task used for analysis. Tasks were designed 
to test aspects of spatial and object memory, executive pro-
cesses, attention and processing speed using tasks similar to 
those used in previous studies examining the effects of aging on 
cognition.74,75 Tasks were presented in the order of simple reac-
tion time, choice reaction time, immediate recognition, con-
gruent Stroop, incongruent Stroop, spatial working memory, 
contextual working memory, delayed recognition. The SUC-
CAB took approximately 30 minutes to complete. The method 
of composition has been described previously.76 Response 
times for the immediate and delayed recognition, spatial work-
ing memory and contextual memory tasks were averaged to 
give the memory composite score. Simple and choice reaction 
time, and the two Stroop task response times were averaged to 
give the attention composite score. Higher scores reflected 
slower response time.
Statistical analyses
IBM SPSS statistics v.23 (Chicago, IL, USA) was used to con-
duct analysis. Pearson’s correlations determined the association 
between age, CVR in various brain regions and composite 
cognitive scores. Linear regressions were performed to assess 
the contribution of CVR in different brain regions to the cog-
nition measures separately. Cognitive score was entered as the 
dependent variable, age, gender, and years of education were 
entered as the independent variables in model one, and CVR 
region entered in model 2. P values of .05 or less were consid-
ered statistically significant in all analyses; however, a correc-
tion for multiple comparisons (Bonferroni’s correction) was 
applied to investigate CVR differences between the age groups 
for the ROI analysis. The level of significance was adjusted on 
eight ROIs (P ⩽ .00625).
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